Close Menu

Columbia

One large ethical issue looming over genomics research concerns whether scientists should let participants know about disease risks and other information found in their genomes.

By Julia Karow
This article has been updated to correct the spelling of Jingyue Ju's name.

Researchers from the National Institutes of Health and Columbia University screened more than 2,800 compounds in 61 Plasmodium falciparum lines, identifying potential anti-malarial agents and using genetic approaches to find loci related to treatment response differences in the malaria parasite.

"What we're going to need to fully take advantage of Watson is to have the genetic and epigenetic information of patients so that the Watson program will be able to utilize and organize that also in medical decision making," said a researcher involved with IBM's efforts to develop an artificial intelligence system that can help doctors diagnose patients accurately and quickly.

There has “been a tremendous shift towards using regulatory, integrative genomic, and kinetic models to understand the biology of drug development [and] disease and using modeling and simulation to predict what the cell is doing.”

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

IP Roundup: Jun 15, 2010

Premium

Biodot, Grace Bio-Labs, Autogenomics, Febit, SRU Biosystems, University of Illinois, Columbia University, New York University

IP Roundup, May 11, 2010

Premium

Columbia University, Riken, Industrial Technology Research Institute, Life Technologies, Syngenta, Petr Nikitin, Johns Hopkins University

The findings help validate Therasis' bioinformatics and systems biology approach to reconstructing maps of regulatory networks in specific cancer cell types.

The company is currently collaborating with Ian Lipkin's lab at Columbia University to co-develop a set of MassTag PCR panels for infectious disease screening that it plans to commercialize some time in the next year.

Pages

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.